Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Male
0301 basic medicine
Adolescent
Short Report
Antibodies, Monoclonal
Colonoscopy
610 Medical sciences; Medicine
Antibodies, Monoclonal, Humanized
Inflammatory Bowel Diseases
Arthritis, Juvenile
canakinumab
3. Good health
Interleukin 1 Receptor Antagonist Protein
systemic JIA
03 medical and health sciences
Treatment Outcome
0302 clinical medicine
ddc: 610
Rheumatology
inflammatory bowel disease
Antirheumatic Agents
Immunology and Allergy
Humans
Pediatrics, Perinatology, and Child Health
anakinra
DOI:
10.1186/s12969-017-0147-3
Publication Date:
2017-03-14T03:24:29Z
AUTHORS (3)
ABSTRACT
Background: Inflammatory bowel disease can develop with some rheumatic diseases in childhood, including juvenile idiopathic arthritis (JIA). Systemic onset JIA has not been connected to inflammatory bowel disease (IBD), but might be connected especially in the context of new treatments. Methods: [for full text, please go to the a.m. URL]<br/>44. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh); 30. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh); 26. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)<br/>
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (19)
CITATIONS (27)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....